Thursday, March 21

SSO 2024 Welcome
Kelly K. Hunt, MD; Callisia Clarke, MD, MS

James Ewing Featured Lecture: Bench to Bedside Translation Through Team Science
Funda Meric Berstam, MD

The Evolution of Sequence of Treatment and Axillary Management in Early-stage Breast Cancer
Laura Dominici, MD; Astrid Botty van den Bruele, MD

Getting the Most out of ERAS Pathways for Patients Undergoing Gastric Cancer Surgery
Evan S. Glazer, MD, PhD, FACS, FSSO; Richelle Williams, MD

American Cancer Society/SSO Diversity, Equity and Inclusion Lecture: Enhancing the Quality of Cancer Case
Patricia L. Turner, MD, MBA, FACS

Cancer Risk, Screening, and Treatment in Sexual and Gender Minority Populations
Lesly A. Dossett, MD, MPH

Surgical Oncology Bowl


Friday, March 22

John Wayne Clinical Research Lecture: Targeting the Cell Cycle Machinery in Cancer-from Bench to the Clinic and Back
Khandan Keyomarsi

Charles M. Balch Distinguished Service Award
2024 Clinical Investigator and Young Investigator Awards

SSO Presidential Address: Empowering Surgeons: A Call for Leadership, Mentorship, and Collaboration in the Field of Surgical Oncology
Kelly K. Hunt, MD

Breast Parallel Session 1
Meeghan A. Lautner, MD, MSc, FACS; Kathie Ann Joseph, MD, MPH

Plenary Session 1
Kelly K. Hunt, MD; Callisia Clarke, MD, MS

Plenary Session 2
Ronald P. DeMatteo, MD, FACS; Cristina Ferrone, MD

Unanswered Questions in Melanoma in 2023
Christina V. Angeles, MD; Genevieve M. Boland, MD, PhD

Cancer surgeons and other clinicians providing care for patients with solid tumors.

Upon completion of the activity, learners should be able to: 

• Describe disparities in surgical oncology care and quality improvement opportunities
• Evaluate cases, including diagnosis, treatment, and outcomes in breast, colorectal/gastrointestinal, endocrine, hepato-pancreato-biliary, melanoma, sarcoma, and peritoneal surface malignancies
• Explain strategies to improve the quality and value of care for surgical oncology patients
• Identify the impact of neoadjuvant systemic therapy and radiation on surgical management of solid tumors
• Incorporate new treatment strategies for surgical oncology, including management and early detection of metastatic disease

The Society of Surgical Oncology (SSO) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Society of Surgical Oncology designates this enduring activity for a maximum of 11.5 AMA PRA Category 1 Credit ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity consists of educational content and evaluation. Learners must view the activity content and complete the post-activity evaluation in order to earn credit. A certificate of credit or participation will be available upon successful submission of the post-activity evaluation.

The estimated time to complete this entire activity is 11.5 hours.

Release Date

          May 3, 2024

CME Expiration Date

          May 3, 2025

As required by the ACCME Standards for Integrity and Independence in Accredited Continuing Education, all planners, reviewers, presenters, instructors, moderators, authors, and other individuals in a position to control or influence the content of an activity must disclose ALL financial relationships with any ineligible company that have occurred within the past 24 months. Ineligible companies are those that cannot be accredited in the ACCME System and whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

As the accredited provider, SSO is responsible for identifying relevant financial relationships between individuals in control of educational content and ineligible companies and managing these to ensure they do not introduce commercial bias into the education. Financial relationships of any dollar amount are defined as relevant if the educational content is related to the business lines or products of the ineligible company.

All identified conflicts of interest must be mitigated, and the educational content vetted for fair balance, scientific objectivity, and appropriateness of patient care recommendations. If you perceive bias while participating in this activity, please advise us of the circumstances when completing your postactivity evaluation form.

All identified conflicts of interests have been mitigated HERE.

The primary purpose of the Society of Surgical Oncology's internet live course is educational. Information, as well as technologies, products, and/or services, discussed are intended to inform participants about the knowledge, techniques, and experiences of specialists who are willing to share such information with colleagues. A diversity of professional opinions exists in the specialty, and the Society of Surgical Oncology disclaims any and all liability for damages to any individual using the materials and for all claims which may result from the use of information, technologies, products, and/or services discussed.

This educational activity may include discussions of unlabeled/unapproved uses of drugs or devices. Participants are advised to refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Opinions expressed in this educational activity are those of the expert contributors and do not necessarily represent the views of the Society of Surgical Oncology or any other organization associated with this activity.

For information about the Society of Surgical Oncology’s privacy policy and associated disclaimer, please visit this site: https://www.surgonc.org/about-sso/privacy-policy/.

System requirements for this activity can be found by clicking the Help button. For technical support, please contact us at expertED@surgonc.org